Case Reports International - Journal for publishing high quality case reports
 
     

Case Report
 
Urinary retention by mirtazapine: A case report
 
Madhav Gajananrao Raje
 
Consultant Psychiatrist, India

Article ID: 100040CRINTMR2017
doi:10.5348/crint-2017-39-CR-8

Address correspondence to:
Dr. Madhav Raje
Consultant Psychiatrist
India

Access full text article on other devices

  Access PDF of article on other devices

[HTML Full Text]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]

How to cite this article
Raje MG. Urinary retention by mirtazapine: A case report. Case Rep Int 2017;6:35–38.


ABSTRACT
Introduction: Mirtazapine is considered to be safest and versatile antidepressant. However, sedation is known to be dose dependent side effect. 7.5 mg/day mirtazapine induces more sedation than 15 mg/day mirtazapine. There is no other side effect of mirtazapine which is reported to be dose dependent.
Case Report: Here is a case, where dose dependent urinary retention is detected. A 38-year-old married female reported with array of recurring symptoms like dysphoria, insomnia, loss of appetite, burning all over, uneasiness, increased frequency of micturation and stool, irritability, frustration, weeping often. She was symptomatic since last five to six years, despite regular psychiatric treatment. Her earlier psychiatrist had expressed inability to treat recurrence and intensity of her symptoms. She was kept on mirtazapine 7.5 mg per day to begin with. She responded favorably. To gain more relief dose of mirtazapine was increased to 15 mg/day. Within one to two days she complained of inability to pass urine. Her complaint was specific that she was not able to empty her bladder completely. After completing the act of micturation she used to experience much discomfort in pelvic region. Further investigations revealed significant urinary retention. Lowering of dose brought her relief immediately.
Conclusion: Mirtazapine with dose of 7.5 mg per day effectively could treat recurring symptoms of a female patient. But increase in dose up to 15 mg/day caused significant side effect of urinary retention against the conventional belief of rise in dose of mirtazapine would increase the relief.

Keywords: Dose dependant side effect, Mirtazapine, Rare adverse effect, Urinary retention


[HTML Full Text]   [PDF Full Text]

Author Contributions
Madhav Gajananrao Raje – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2017 Madhav Gajananrao Raje. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.


ABOUT THE AUTHOR

Madhav Gajananrao Raje is consultant psychiatrist and psychotherapist at Nagpur, India. Qualifications: MD (FMT), DFM (Famiily Medicine), DPM (Psychiatry), MSc CFT (Counseling and Family Therapy), BA Psychology, MA Philosophy, DPC. He has published 10 research papers in national & international Journals. He has authored a book individually and authored two chapters in a reference multi-authored book. His research interests include Adult ADHD, OCD, psychotropic medicine, multi centered psychiatric research projects. He intends to pursue academic collaboration with other researchers in the field of psychology/psychiatry.





  Home line About the Journal line Aim and Scope line Sections line Open Access line Archives
Apply as Editor line Apply as Reviewer line Submit Reviews - Editors line Submit Reviews - Reviewers
Instructions for Authors line Templates to Use line Copyright Form line Author Checklist
Online Submission line Email Submission line Submit Revision line Submit All Forms line Submit Page Proofs
Terms of Service line Privacy policy line Disclaimer line FAQ line Contact: Journal line Contact: Edorium Journals line Site Map
 
  Copyright © 2015. Edorium. All rights reserved.